A carregar...
Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial
BACKGROUND: Trials using mineralocorticoid receptor antagonists (MRAs) in myocardial infraction (MI) without heart failure (HF) or systolic impairment have been underpowered to assess morbidity‐mortality benefit. In EPHESUS 6632 patients were included, of whom 11% had an ejection fraction (EF) of 40...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6837025/ https://ncbi.nlm.nih.gov/pubmed/31482613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23261 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|